Pleural effusion as a sample matrix for laboratory analyses in cancer management: a perspective

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00179906%3A_____%2F25%3A10497664" target="_blank" >RIV/00179906:_____/25:10497664 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11150/25:10497664 RIV/61989592:15110/25:73635109 RIV/00098892:_____/25:10159350

Výsledek na webu

<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=i6Gg95krd0" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=i6Gg95krd0</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1515/cclm-2025-0197" target="_blank" >10.1515/cclm-2025-0197</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Pleural effusion as a sample matrix for laboratory analyses in cancer management: a perspective

Popis výsledku v původním jazyce

Malignant effusions, pleural effusion or ascites, represent a common problem in cancer patients. Pleural effusion in a cancer patient may be caused also by non-neoplastic conditions, and the diagnosis of malignant pleural effusion is established by the demonstration of tumor cells in pleural fluid. Microscopical detection of tumor cells in pleural fluid often fails, and there is an unmet medical need for more sensitive methods. New approaches, including isolation using magnetic beads coated with monoclonal antibodies targeting antigens expressed on tumor cells not only increase the diagnostic sensitivity, but also provide material for the analysis of predictive biomarkers. The advent of new technologies illustrates the incremental role of laboratory medicine in the management of patients with malignant effusions.

Název v anglickém jazyce

Pleural effusion as a sample matrix for laboratory analyses in cancer management: a perspective

Popis výsledku anglicky

Malignant effusions, pleural effusion or ascites, represent a common problem in cancer patients. Pleural effusion in a cancer patient may be caused also by non-neoplastic conditions, and the diagnosis of malignant pleural effusion is established by the demonstration of tumor cells in pleural fluid. Microscopical detection of tumor cells in pleural fluid often fails, and there is an unmet medical need for more sensitive methods. New approaches, including isolation using magnetic beads coated with monoclonal antibodies targeting antigens expressed on tumor cells not only increase the diagnostic sensitivity, but also provide material for the analysis of predictive biomarkers. The advent of new technologies illustrates the incremental role of laboratory medicine in the management of patients with malignant effusions.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30204 - Oncology

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2025

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Clinical Chemistry and Laboratory Medicine

ISSN

1434-6621

e-ISSN

1437-4331

Svazek periodika

63

Číslo periodika v rámci svazku

6

Stát vydavatele periodika

DE - Spolková republika Německo

Počet stran výsledku

6

Strana od-do

1069-1074

Kód UT WoS článku

001434013800001

EID výsledku v databázi Scopus

2-s2.0-86000182021